Evaluation of antibody response and nonspecific lymphocyte blastogenesis following inoculation of a live attenuated bluetongue virus vaccine in goats

American Journal of Veterinary Research

Volumn 65, Issue 10, 2004, Pages 1331-1334

  Lacetera, Nicola ^a   Ronchi, Bruno ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; DNA; LIVE VACCINE; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; BLUETONGUE ORBIVIRUS; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG SAFETY; EXPERIMENTATION; FEMALE; GOAT; INOCULATION; ITALY; LYMPHOCYTE TRANSFORMATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SEROTYPE; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BLUETONGUE VIRUS; CONCANAVALIN A; DNA REPLICATION; GOATS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PHYTOHEMAGGLUTININS; POKEWEED MITOGENS; TIME FACTORS; VACCINES, ATTENUATED; VIRAL VACCINES;

ANIMALIA; BLUETONGUE VIRUS; CAPRA HIRCUS; ORBIVIRUS; PHYTOLACCACEAE;

EID: 5644270238     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.1331     Document Type: Article

References (24)

1. MacLachlan NJ, Conley AJ, Kennedy PC. Bluetongue and equine viral arteritis viruses as models of virus-induced fetal injury and abortion. Anim Reprod Sci 2000;60-61:643-651.
2. Murray PK, Eaton BT. Vaccines for bluetongue. Aust Vet J 1996;73:207-210.
3. Schultz G, Dyce AL, Muller MJ. Losses in newborn lambs associated with bluetongue vaccination of pregnant ewes. J Am Vet Med Assoc 1955;128:224-226.
4. Young S, Cordy DR. An ovine fetal encephalopathy caused by bluetongue vaccine virus. J Neuropathol Exp Neurol 1964; 23:635-659.
5. Hunter P, Modumo J. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep. Onderstepoort J Vet Res 2001;68:331-333.
6. Hammoumi S, Breard E, Sailleau C, et al. Studies of the safety and immunogenicity of the South African bluetongue virus serotype 2 monovalent vaccine: specific detection of the vaccine strain genome by RT-PCR. J Vet Med B 2003;50:316-321.
7. Jacobson RM, Zabel KS, Poland GA. The overall safety profile of currently available vaccines directed against infectious diseases. Expert Opin Drug Saf 2003;2:215-223.
8. Odeón AC, Schore CE, Osburn BI. The role of cell-mediated immunity in the pathogenesis of bluetongue virus serotype 11 in the experimental infection of vaccine/sensitized calves. Comp Immunol Microbiol Infect Dis 1997;20:219-232.
9. Eskra L, Splitter GA. Bovine herpesvirus-1 infects activated CD4+ lymphocytes. J Gen Virol 1997;78:2159-2166.
10. Lacetera N, Bernabucci U, Ronchi B, et al. Effects of subclinical pregnancy toxemia on immune responses in sheep. Am J Vet Res 2001;62:1020-1024.
11. Lacetera N, Bernabucci U, Ronchi B, et al. Moderate summer heat stress does not modify immunological parameters of Holstein dairy cows. Int J Biometeorol 2002;46:33-37.
12. MacLachlan NJ, Schore CE, Osburn BI. Lymphocyte blastogenesis in bluetongue virus or Mycobacterium bovis-inoculated bovine fetuses. Vet Immunol Immunopathol 1984;7:11-18.
13. Stott JL, Blanchard-Channell M, Scibienski RJ, et al. Interaction of bluetongue virus with bovine lymphocytes. J Gen Virol 1990;71:363-368.
14. Leite F, Sylte MJ, O'Brien S, et al. Effect of experimental infection of cattle with bovine herpesvirus-1 (BHV-1) on the ex vivo interaction of bovine leukocytes with Mannheimia (Pasteurella) haemolytica leukotoxin. Vet Immunol Immunopathol 2002; 84:97-110.
15. Noel EJ, Israel BA, Letchworth GJ, et al. Effects of immunization with bovine herpesvirus-1 glycoproteins on bovine herpesvirus-1-induced alteration of bovine neutrophil chemotactic and anti-Pasteurella haemolytica activities. Vaccine 1988;6:433-439.
16. Pukhalsky AL, Shmarina GV, Bliacher MS, et al. Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination. Mediators Inflamm 2003; 12:203-207.
17. Dhein CR, Gorham JR. Host response to vaccination. Vet Clin North Am Small Anim Pract 1986;16:1227-1245.
18. Foley JE, Orgad U, Hirsh DC, et al. Outbreak of fatal salmonellosis in cats following use of a high-titer modified-live panleukopenia virus vaccine. J Am Vet Med Assoc 1999;214:67-70.
19. OIE Web site. Principles of veterinary vaccine production. Manual of standards for diagnostic tests and vaccines for terrestrial animals 2000, Chapter 1.1.6. Available at: www.oie.int/eng/normes/mmanual/A_00017.htm. Accessed Dec 15, 2003.
20. Greenwood PL. Effects of caprine arthritis-encephalitis virus on productivity and health of dairy goats in New South Wales, Australia. Prev Vet Med 1995;22:71-87.
21. Martinez-Moreno A, Jimenez-Luque V, Camara S, et al. Oxidative responses during bacterial phagocytosis of polymorphonuclear leucocytes in primarily and secondarily Fasciola hepatica infected goats. Int J Parasitol 2000;30:1013-1017.
22. Strassera A, Maya B, Teltschera A, et al. Immune modulation following immunization with polyvalent vaccines in dogs. Vet Immunol Immunopathol 2003;94:113-121.
23. Koumbati M, Mangana O, Nomikou K, et al. Duration of bluetongue viraemia and serological responses in experimentally infected European breeds of sheep and goats. Vet Microbiol 1999;64:277-285.
24. Third International Symposium on Bluetongue: conclusions. Vaccines & vaccinations - group 4. Available at: www.bluetonguesymposium.it/vaccines.htm. Accessed Feb 20, 2004.